Publication | Open Access
Patient Preference and Treatment Satisfaction With a Port Delivery System for Ranibizumab vs Intravitreal Injections in Patients With Neovascular Age-Related Macular Degeneration
22
Citations
19
References
2022
Year
ClinicalTrials.gov Identifier: NCT03677934.
| Year | Citations | |
|---|---|---|
Page 1
Page 1